Cost-Effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-Line Chemotherapy in Japancost-effectivenessgastric cancerMarkov modelpaclitaxelramucirumabAdding ramucirumab to a regimen of paclitaxel in the second-line treatment of advanced gastric cancer is...
5-fluorouracil-based regimens were universal, and also some new agents were involved, such as docetaxel, paclitaxel, and oxaliplatin. By processing analysis, we could recommend etoposide, leucovorin and 5-fluorouracil (ELF) regimen as preference, with a DMC/MST ratio of 2543 RBM/11.7 mo and a...
Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer: a European perspective. Eur J Cancer 1998 Nov; 34: 1894–901Berger K,Fischer T,Szucs TD.Cost effectiveness analysis of paclitaxel and cisplatin versus ...
Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer. Even though the TP combination has a considerably higher drug acquisition cost, the results of the current analysis suggest that this new chemotherapy ... A Ortega,G Dranitsaris,J Sturgeon,...
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947-957. doi:10.1056/NEJMoa0810699PubMedGoogle ScholarCrossref 4. Wu YL, Zhou C, Hu CP, et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non...
Sequencing complexities with chemotherapy-based regimens in metastatic breast cancer pose unique challenges for valuebased decision-making in routine practice.
Results Total chemotherapy line durations and off treatment durations were highly variable and decreased across treatment lines. Taxane-based chemotherapies (docetaxel and paclitaxel) were the most often used regimens in the first two lines of treatment. Afterwards, capecitabine, vinorelbine and ...
Esophageal carcinoma is a type of cancer that occurs in the esophagus. For patients with locally advanced or metastatic esophageal squamous cell carcinoma who have either experienced disease progression following first-line standard chemotherapy or are intolerant to it, the prognosis is typically poor. ...
Disclosed herein a cost effective, improved, continuous process for production of Paclitaxel from endophytic fungi, Fusarium solani, with substantially high yield. In an aspect, the process for the production of paclitaxel includes preparing the autoclaved culture media, preparing the inoculum followed by...
However, In the large-scale phase III ICON7 (ISRCTN91273375) and GOG-0218 (NCT00262847) trials revealed that the median progression-free survival (PFS) of AOC patients that underwent this combination of surgery and chemotherapy was just 10–17 months, with themajority of these individuals ...